The expression of β-catenin is shown to be regulated by BCR::ABL1 via the PI3K/AKT pathway and to enhance the leukaemic progression in a CML murine model (Figure 3) [75]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.